Both Epac1 and Epac2 are expressed in the pancreas (Leech et al., 2000), and under high glucose conditions, Ca 2+ flows into cells through VDC channels, and Epac2 opens RYR calcium channels in the endoplasmic reticulum, further increasing intracellular Ca 2+ concentrations and enhancing exocytosis of insulin-secreting vesicles (Holz, 2004
Other tests that are performed to guarantee structural integrity and minimal contaminants include: additional tests, which are thin-layer chromatography and amino acid analysis
BMC Endocrine Disorders , 19 (1).
A more detailed review of data by the FDA showed that GLP-1 drugs do not increase the risk of suicidal ideation or behavior
GLP-1 Medicare Drug Negotiation Price List In January 2025, the Centers for Medicare and Medicaid Services (CMS) announced the inclusion of GLP-1 receptor agonists specifically semaglutide-based medications Ozempic, Wegovy and Rybelsus in the second cycle of the Medicare Drug Price Negotiation Program, as per the Inflation Reduction Act
The post hoc analysis of pooled data from the Semaglutide Treatment Effect in People with Obesity (STEP) 1, 2, 3, and 5 trials indicated that semaglutide treatment at 2.4 mg did not increase the risk of depressive symptoms or suicidal ideation compared to placebo, while demonstrating a statistically significant yet clinically negligible decrease in depressive symptoms [75]